PROX1 and astrocytoma (excluding glioblastoma): Alternatively, and based on our previous findings in diffuse low-grade gliomas, PROX1 may be a prognostic marker for IDH-mutant astrocytomas that have progressed from pre-existing low-grade tumors [12].